STAT

New WHO leader should focus on the crushing burden of noncommunicable diseases and injuries

With a new leader at the helm, WHO must focus on the crushing burden of noncommunicable diseases and injuries on the world's poorest people and communities.
A focus on noncommunicable diseases and injuries by new WHO Director-General Tedros Adhanom Ghebreyesus could help move forward his goal for universal health coverage for all.

As Tedros Adhanom Ghebreyesus of Ethiopia takes the helm of the World Health Organization this week as its eighth Director-General, and the first from sub-Saharan Africa, he has set an ambitious agenda for the organization. During his campaign for the office and since his election, Tedros has consistently emphasized WHO’s important role as a guardian of equity — in particular ensuring that the world’s poorest populations have access to health care as a fundamental human right.

As practitioners and advocates for improving the health of the world’s poorest and most vulnerable people, we applaud Tedros and WHO for

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks